3D Global Biotech Inc. (TPEX:6808)
Taiwan
· Delayed Price · Currency is TWD 60.00
+2.50 (4.35%)
Feb 21, 2025, 1:34 PM CST
3D Global Biotech Market Cap
3D Global Biotech has a market cap or net worth of 4.70 billion as of February 21, 2025. Its market cap has increased by 326.55% in one year.
Market Cap
4.70B
Enterprise Value
4.37B
Revenue
55.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
60.00
Market Cap Chart
Since December 25, 2020, 3D Global Biotech's market cap has increased from 2.74B to 4.70B, an increase of 71.82%. That is a compound annual growth rate of 13.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 4.70B | -8.37% |
| Dec 31, 2024 | 5.13B | 371.49% |
| Dec 29, 2023 | 1.09B | -27.35% |
| Dec 30, 2022 | 1.50B | -30.09% |
| Dec 30, 2021 | 2.14B | -18.98% |
| Dec 31, 2020 | 2.64B | -3.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 213.05B |
| Caliway Biopharmaceuticals | 142.70B |
| Bora Pharmaceuticals Co., LTD. | 90.22B |
| Lotus Pharmaceutical | 72.97B |
| Lumosa Therapeutics | 39.69B |
| Oneness Biotech | 38.96B |
| Polaris Group | 34.55B |
| Pegavision | 30.65B |